The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Enhancing the bioavailability of resveratrol by combining it with piperine
Open accessAbstract
Scope:Resveratrol (3,5,4′‐trihydroxystilbene) is a phytoalexin shown to possess a multitude of health‐promoting properties in pre‐clinical studies. However, the poor in vivo bioavailability of resveratrol due to its rapid metabolism is being considered as a major obstacle in translating its effects in humans. In this study, we examined the hypothesis that piperine will enhance the pharmacokinetic parameters of resveratrol via inhibiting its glucuronidation, thereby slowing its elimination. Methods and results:Employing a standardized LC/MS assay, we determined the effect of piperine co‐administration with resveratrol on serum levels resveratrol and resveratrol‐3‐O‐β‐D‐glucuronide in C57BL mice. Mice were administered resveratrol (100 mg/kg;oral gavage) or resveratrol (100 mg/kg;oral gavage)+piperine (10 mg/kg;oral gavage), and the serum levels of resveratrol and resveratrol‐3‐O‐β‐D‐glucuronide were analyzed at different times. We found that the degree of exposure (i.e. AUC) to resveratrol was enhanced to 229% and the maximum serum concentration (Cmax) was increased to 1544% with the addition of piperine. Conclusion:Our study demonstrated that piperine significantly improves the in vivo bioavailability of resveratrol. However, further detailed research is needed to study the mechanism of improved bioavailability of resveratrol via its combination with piperine as well as its effect on resveratrol metabolism.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Therapeutic potential of resveratrol: the in vivo evidence
Baur, J. A., & Sinclair, D. A. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2060 · Cited by 3,958
Wine, alcohol, platelets, and the French paradox for coronary heart disease
Renaud, S., & de Lorgeril, M. (1992) · The Lancet · doi:10.1016/0140-6736(92)91277-f · Cited by 3,643
PKSolver: An add-in program for pharmacokinetic and pharmacodynamic data analysis in Microsoft Excel
Zhang, Y., Huo, M., Zhou, J., & Xie, S. (2010) · Computer Methods and Programs in Biomedicine · doi:10.1016/j.cmpb.2010.01.007 · Cited by 2,058
HIGH ABSORPTION BUT VERY LOW BIOAVAILABILITY OF ORAL RESVERATROL IN HUMANS
Walle, T., Hsieh, F., DeLegge, M. H., Oatis, J. E., & Walle, U. K. (2004) · Drug Metabolism and Disposition · doi:10.1124/dmd.104.000885 · Cited by 1,880
Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers
Shoba, G., Joy, D., Joseph, T., Majeed, M., Rajendran, R., & Srinivas, P. (1998) · Planta Medica · doi:10.1055/s-2006-957450 · Cited by 1,656
Boocock, D. J., Faust, G. E. S., Patel, K. R., Schinas, A. M., Brown, V. A., Ducharme, M. P., Booth, T. D., Crowell, J. A., Perloff, M., Gescher, A. J., et al. (2007) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-07-0022 · Cited by 824
Black Pepper and its Pungent Principle-Piperine: A Review of Diverse Physiological Effects
Srinivasan, K. (2007) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408390601062054 · Cited by 821
Brown, V. A., Patel, K. R., Viskaduraki, M., Crowell, J. A., Perloff, M., Booth, T. D., Vasilinin, G., Sen, A., Schinas, A. M., Piccirilli, G., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-2364 · Cited by 688
Marier, J.-F., Vachon, P., Gritsas, A., Zhang, J., Moreau, J.-P., & Ducharme, M. P. (2002) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.033340 · Cited by 480
Almeida, L., Vaz‐da‐Silva, M., Falcão, A., Soares, E., Costa, R., Loureiro, A. I., Fernandes‐Lopes, C., Rocha, J., Nunes, T., Wright, L., et al. (2009) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200800177 · Cited by 426
Cancer Chemopreventive Activity of Resveratrol
BHAT, K. P. L., & PEZZUTO, J. M. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb02918.x · Cited by 398
Chemoprevention by resveratrol: molecular mechanisms and therapeutic potential
Shankar, S. (2007) · Frontiers in Bioscience · doi:10.2741/2432 · Cited by 342
Resveratrol Modulates Drug- and Carcinogen-Metabolizing Enzymes in a Healthy Volunteer Study
Chow, H.-H. S., Garland, L. L., Hsu, C.-H., Vining, D. R., Chew, W. M., Miller, J. A., Perloff, M., Crowell, J. A., & Alberts, D. S. (2010) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-09-0155 · Cited by 330
Sale, S., Verschoyle, R. D., Boocock, D., Jones, D. J. L., Wilsher, N., Ruparelia, K. C., Potter, G. A., Farmer, P. B., Steward, W. P., & Gescher, A. J. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601568 · Cited by 260
Nonomura, S., Kanagawa, H., & Makimoto, A. (1963) · YAKUGAKU ZASSHI · doi:10.1248/yakushi1947.83.10_988 · Cited by 230
Chemoprevention of skin cancer by grape constituent resveratrol: relevance to human disease?
Aziz, M. H., Reagan‐Shaw, S., Wu, J., Longley, B. J., & Ahmad, N. (2005) · The FASEB Journal · doi:10.1096/fj.04-3582fje · Cited by 220
Self-citationPiperine enhances the bioavailability of the tea polyphenol (-)-epigallocatechin-3-gallate in mice
Lambert, J. D., Hong, J., Kim, D. H., Mishin, V. M., & Yang, C. S. (2004) · The Journal of Nutrition · doi:10.1093/jn/134.8.1948 · Cited by 213
Green tea polyphenols for prostate cancer chemoprevention: A translational perspective
Johnson, J. J., Bailey, H. H., & Mukhtar, H. (2010) · Phytomedicine · doi:10.1016/j.phymed.2009.09.011 · Cited by 202
Self-citationAtal, C. K., Dubey, R. K., & Singh, J. (1985) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)20081-7 · Cited by 180
Burkon, A., & Somoza, V. (2008) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200700290 · Cited by 180
Protein composition of bovine lens cortical fiber cell membranes
Alcalá, J., Lieska, N. G., & MAISEL, H. (1975) · Experimental Eye Research · doi:10.1016/0014-4835(75)90040-8 · Cited by 170
Piperine Inhibits Gastric Emptying and Gastrointestinal Transit in Rats and Mice
Bajad, S. U., Bedi, K. L., Singla, A. K., & Johri, R. K. (2001) · Planta Medica · doi:10.1055/s-2001-11505 · Cited by 115
Effect of food on the pharmacokinetic profile of trans-resveratrol
Vaz‐da‐Silva, M., Loureiro, A. I., Falcão, A. C., Nunes, T., Rocha, J.-F., Fernandes‐Lopes, C., Soares, E., Wright, L. C., Almeida, L., & Soares-da-Silva, P. (2008) · International Journal of Clinical Pharmacology and Therapeutics · doi:10.5414/cpp46564 · Cited by 105
Resveratrol in cancer management: where are we and where we go from here?
Ndiaye, M. A., Kumar, R., & Ahmad, N. (2011) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05851.x · Cited by 98
Self-citationJohnson, J. J., Syed, D. N., Suh, Y. K., Heren, C. R., Saleem, M., Siddiqui, I. A., & Mukhtar, H. (2010) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-10-0168 · Cited by 88
Self-citationGlucuronidation of trans -resveratrol by human liver and intestinal microsomes and UGT isoforms
Brill, S., Furimsky, A. M., Ho, M. N., Furniss, M. J., Li, Y., Green, A. G., Green, C. E., Iyer, L., Bradford, W. W., & Kapetanović, I. M. (2006) · Journal of Pharmacy and Pharmacology · doi:10.1211/jpp.58.4.0006 · Cited by 77
Reagan‐Shaw, S., Mukhtar, H., & Ahmad, N. (2008) · Photochemistry and Photobiology · doi:10.1111/j.1751-1097.2007.00279.x · Cited by 64
Self-citationCharacterization of a new rat urinary metabolite of piperine by LC/NMR/MS studies
Bajad, S. U., Coumar, M. S., Khajuria, R. K., Suri, O. P., & Bedi, K. L. (2003) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(03)00143-x · Cited by 45
Oncogenicity evaluation of resveratrol in p53(±) (p53 knockout) mice
Horn, T. L., Cwik, M., Morrissey, R. L., Kapetanović, I. M., Crowell, J. A., Booth, T. D., & McCormick, D. L. (2006) · Food and Chemical Toxicology · doi:10.1016/j.fct.2006.07.015 · Cited by 38
Cited by
The Role of Resveratrol in Cancer Therapy
Ko, J.-H., Sethi, G., Um, J.-Y., Shanmugam, M. K., Arfuso, F., Kumar, A. P., Bishayee, A., & Ahn, K. S. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18122589 · Cited by 800
Administration of resveratrol: What formulation solutions to bioavailability limitations?
Amri, A., Chaumeil, J. C., Sfar, S., & Charrueau, C. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.09.083 · Cited by 620
Resveratrol and cancer: focus on in vivo evidence
Carter, L. G., D'Orazio, J. A., & Pearson, K. J. (2014) · Endocrine-Related Cancer · doi:10.1530/erc-13-0171 · Cited by 522
Resveratrol and Clinical Trials: The Crossroad from In Vitro Studies to Human Evidence
Tomé-Carneiro, J., Larrosa, M., González-Sarrías, A., Tomás-Barberán, F., García-Conesa, M., & Espín, J. (2013) · Current Pharmaceutical Design · doi:10.2174/13816128113199990407 · Cited by 449
Piperine—The Bioactive Compound of Black Pepper: From Isolation to Medicinal Formulations
Gorgani, L., Mohammadi, M., Najafpour, G. D., & Nikzad, M. (2017) · Comprehensive Reviews in Food Science and Food Safety · doi:10.1111/1541-4337.12246 · Cited by 399
Metadata
- Authors
- Johnson, J. J., Nihal, M., Siddiqui, I. A., Scarlett, C. O., Bailey, H. H., Mukhtar, H., & Ahmad, N.
- Venue
- Molecular Nutrition & Food Research
- Publisher
- Wiley
- Published
- 2011-06-29
- Volume
- 55
- Issue
- 8
- Pages
- 1169-1176
- ISSN
- 1613-4125 (ISSN-L)
- 1613-4133
- OpenAlex
- W2057355419
- Cited by
- 339
- References
- 30
- FWCI
- 7.32
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.